glp-1 prescriptions growth q1 2025 Receptor Agonist Market Analysis Eli Lilly Q1 2025 slides:

Common symptoms include dizziness, lightheadedness, blurred vision, fatigue, nausea, difficulty concentrating, and in severe cases, syncope (fainting)

Fermented foods like yogurt, kefir, kimchi, and sauerkraut support microbiome diversity

Not enough insurers signed on for the voluntary plan by the April deadline, so CMS instead announced it would extend the Bridge program to 18 months, with a new end date of December 2027

GLP-1 receptor agonists are medications that mimic a natural hormone in your body called glucagon-like peptide-1 [GLP-1], explains Thomas Tsang, MD, MPH, Chief Medical Officer at Omada Health

DeFronzo RA, Tripathy D

Fiber slows the emptying of the stomach, almost acting as a natural GLP-1